secwatch.observer — SEC 8-K summary
======================================

Issuer:     agilon health, inc. (AGL)
CIK:        0001831097
Form:       8-K
Filed at:   2023-03-01T23:59:59+00:00
Accession:  0000950170-23-005516
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

agilon health Q4 revenue up 49% to $690M; FY2022 Adjusted EBITDA turns positive; guides 2023 EBITDA $75-90M
--------------------------------------------------------------------------------

- Q4 revenue $690M (+49% YoY); FY2022 revenue $2.71B (+48%). Medicare Advantage members 269,500 (+45%).
- Q4 medical margin $61M (+93%); FY2022 medical margin $305M (+67%). Medical margin rate 8.8% Q4, 11.2% FY.
- Q4 net loss $57M (flat YoY); FY2022 net loss $107M vs $407M (includes $292M non-cash stock comp in 2021).
- FY2022 Adjusted EBITDA positive $4M vs negative $39M; Q4 Adjusted EBITDA negative $11M vs negative $27M.
- Completed acquisition of mphrX on Feb 28, 2023; expects 2023 revenue $4.28-4.37B, Adjusted EBITDA $75-90M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831097/000095017023005516/0000950170-23-005516-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831097/000095017023005516/agl-20230301.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-005516

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer